About Us



Who we are

Clinixir is a full-service Contract Research Organization (CRO) that partners with pharmaceutical, biotech, and life sciences companies to deliver high-quality clinical research and bring innovative therapies to patients—faster and more efficiently.

Clinix_Home_01
Clinix_Home_03

We support the development of safe, effective treatments with precision, speed, and regulatory confidence.

Backed by a highly experienced team and deep knowledge of Thailand’s clinical landscape, we ensure each study is delivered on time, within budget, and in full compliance with international standards.

 

Clinixir helps sponsors bring impactful therapies to market while enhancing outcomes for patients and healthcare systems alike. 

Partner with Clinixir and move forward with a smarter, more reliable approach to clinical research.

 

 

" Clinixir helps sponsors bring impactful therapies to market while enhancing outcomes for patients and healthcare systems alike. "

Our Partners

Clinixir maintains strong partnerships with six leading medical institutions across Thailand, who also serve as our key stakeholders. These institutions provide essential support across all clinical trial phases, ensuring access to world-class clinical trial sites, efficient patient recruitment, and seamless Ethics Committee submissions.


Our close collaboration with these stakeholders strengthens Clinixir’s ability to deliver high-quality clinical research outcomes while ensuring compliance with international standards. This trusted network empowers us to provide the best possible results for our sponsors.

 

Clinix_Uni-CU-03
Clinix_Uni-TU-03
Clinix_Uni-MU-Rama-03
Clinix_Uni-MU-Tropical-03
Clinix_Uni-MU-Srisirat-03
Clinix_Uni-CMU-03
Clinix_Uni-Khonkaen-03
Clinix_Uni-Songkla-03
CU
Logo-TMS
MU
CMU
Logo_KK
Logo_PSK

Our Vision and Mission

Vision

To strengthen clinical research capabilities, support local innovations, attract global investment, and drive economic growth in Thailand

Mission

To provide world-class one-stop clinical research services that meets international standards for medical product development

Quality and Compliance

Clinix_ISO-9001-white

Our Core Values

CLX_icon_Lifelong-Learning5-2

Lifelong Learning

Fostering Excellence Through Lifelong Learning and Growth

CLX_icon_Collaborative-Empathy2-2

Collaborative Empathy

A Unity of Hearts, Communication Without Borders

CLX_icon_Adaptive-Quality3-2

Adaptive Quality

Exceeding Expectations with Adaptive Excellence

CLX_icon_Customer-Centric4-2

Customer-Centric Ethical Service

A Unity of Hearts, Communication Without Borders

Advancing Healthcare Decision-Making Through Network Meta-Analysis

Advancing Healthcare Decision-Making Through Network Meta-Analysis

May 30, 2025 2:38:19 PM 2 min read
Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

May 26, 2025 11:14:05 AM 2 min read
Is Your EDC System Future-Proof?

Is Your EDC System Future-Proof?

May 23, 2025 10:21:28 AM 4 min read

Our Core Values

Frame 9-1

Lifelong Learning

Fostering Excellence Through Lifelong Learning and Growth

Frame 7

Collaborative Empathy

A Unity of Hearts, Communication Without Borders

Frame 8

Adaptive Quality

Exceeding Expectations with Adaptive Excellence

Frame 6

Customer-Centric Ethical Service

A Unity of Hearts, Communication Without Borders

Advancing Healthcare Decision-Making Through Network Meta-Analysis

Advancing Healthcare Decision-Making Through Network Meta-Analysis

May 30, 2025 2:38:19 PM 2 min read
Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

May 26, 2025 11:14:05 AM 2 min read
Is Your EDC System Future-Proof?

Is Your EDC System Future-Proof?

May 23, 2025 10:21:28 AM 4 min read

Board of Directors

Clinix_BOD-Charamporn-2

Mr. Charamporn Jotikasthira
Executive Director, Bangkok Bank PCL

Clinix_BOD-Artit-1

Clinical Professor Artit Ungkanont, M.D.
Dean, President, The Executive Committee of Ramathibodi Foundation

Clinix_BOD-Dr.Pao-2

Dr. Pao Sriprasertsuk
SVP, Manager of Innovation Department
Bangkok Bank PCL

Clinix_BOD-Piyamitr-2

Prof. Piyamitr Sritara, M.D.
President of Mahidol University

Clinix_BOD-Apichat Asavamongkolku-2

Prof. Apichat Asavamongkolkul, M.D.
Dean, Faculty of Medicine Siriraj University

Clinix_BOD-Ruchanee-1

Mrs. Ruchanee Nopmuang
Advisor Bangkok Bank Public Company Limited

Clinix_BOD-Pyatat-2

Prof. Pyatat Tatsanavivat, M.D
Medical Research Network

Clinix_BOD-Auchara-2

Assoc. Prof. Auchara Tangsathapornpong, M.D.
Dean, Faculty of Medicine Thammasat University

Clinix_BOD-Kittipong-2

Asst. Prof. Kittipong Riabroi, M.D.
Dean, Faculty of Medicine Prince of Songkla University

Clinix_BOD-Charamporn-2


Mr. Charamporn Jotikasthira

Executive Director, Bangkok Bank PCL

 

Clinix_BOD-Piyamitr-2


Prof. Piyamitr Sritara

M.D. President of Mahidol University

 

Clinix_BOD-Pyatat-2


Prof. Pyatat Tatsanavivat, M.D.

Medical Research Network

 

Clinix_BOD-Artit-1


Clinical Professor Artit Ungkanont, M.D.

Dean, President, The Executive Committee of Ramathibodi Foundation

 

Clinix_BOD-Apichat Asavamongkolku-2


Prof. Dr. Apichat Asavamongkolkul, M.D.

Dean, Faculty of Medicine Siriraj University

 

Clinix_BOD-Auchara-2


Assoc. Prof. Auchara Tangsathapornpong, M.D.

Dean, Faculty of Medicine Thammasat University

 

Clinix_BOD-Dr.Pao-2


Dr. Pao Sriprasertsuk

SVP, Manager of Innovation Department
Bangkok Bank PCL

 

Clinix_BOD-Ruchanee-1


Mrs. Ruchanee Nopmuang

Advisor Bangkok Bank Public Company Limited

 

Clinix_BOD-Artit-1


Clinical Professor Artit Ungkanont, M.D.

Dean, President, The Executive Committee of Ramathibodi Foundation

 

Latest News & Updates

Discover our latest news and updates to stay on top of clinical research trends and topics such as decentralized clinical trialspharmacovigilance, treatment development, medical innovations, clinical trial phases, careers in clinical research, and much more.

Advancing Healthcare Decision-Making Through Network Meta-Analysis

Advancing Healthcare Decision-Making Through Network Meta-Analysis

May 30, 2025 2:38:19 PM 2 min read
Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

May 26, 2025 11:14:05 AM 2 min read
Is Your EDC System Future-Proof?

Is Your EDC System Future-Proof?

May 23, 2025 10:21:28 AM 4 min read
"I am very pleased to update everyone that the First Country Subject has been enrolled by Thailand Team on 11 October 2023 at site THA-764-002! After all from the start up process up to getting the approval, trainings, documentations, we have finally made it. I know this is not easy, So I want to take this opportunity to give thanks to the site, Clinixir and to the AZ Thailand study team for your hard work!"
“Tech Observer would like to thank Clinixir for your close collaboration with the sponsor and us during the recent PY8 application process. Your diligent efforts in supporting the sponsor and coordinating with the sites to obtain the necessary documents for PY8 are commendable. Additionally, Clinixir's attendance for a telephone conference with the sponsor on short notice is highly appreciated. The sponsor is deeply thankful for your dedication and support. Thank you.!”
“I am delighted to hear the news and I extend my heartfelt congratulations to each one of your team for reaching this milestone. It reflects the dedication and hard work put forth through exceptional teamwork. Let us carry forward the momentum, enthusiasm, and collaborative spirit to achieve the upcoming milestones. Great job team.”
“We are highly impressed with Clinixir's team, whose professionalism and expertise have greatly contributed to the success of our project.”
“The Sponsor extends their gratitude to K Purada and the Clinixir CRAs/CTA for their invaluable assistance and dedication in successfully cleaning and locking the ChulaVac006 database for the project's interim analysis as planned on February 16, 2024. Your efforts are greatly appreciated.”
“Thank you for your kind support in ensuring the cleaning and locking of the ChulaVac006 interim analysis database as planned. The sponsor greatly appreciates your dedication.Suttipong Chinkrua.”

Subscribe to our monthly newsletter

Sign up to our monthly newsletter to get the latest news and updates delivered directly in your inbox